In TBI survivors evaluated with GHRH plus GHRP‑6, severe GH deficiency occurred in 15%.
In plain wordsThe combined test identified severe GH deficiency in 15% of TBI survivors.
- Peptide
- GHRP-6
- Outcome
- Not applicableSevere GH deficiency
- Study
n = 67
- Outcome group
- Growth hormone and IGF-1 · Endocrine and hormones
Measurements
- Severe GH deficiency
- 15%
- TBI patients
Source sentences
Severe GHD is the most frequent deficiency present in 15% of TBI patients.
2 context sentences(design, population, supporting numbers)
We present the results of endocrine, neurological, neuropsychological and psychiatric evaluation in a group of 67 patients who suffered TBI at least one yr ago.
GH/IGF-I axis was evaluated by GHRH+GHRP-6 test and IGF-I measurement.
In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.